Art. 18 Regulation (EU) 2016/161

Actions to be taken by manufacturers in case of tampering or suspected falsification

In forcesince 2 Oct 2015

Where a manufacturer has reason to believe that the packaging of the medicinal product has been tampered with, or the verification of the safety features shows that the product may not be authentic, the manufacturer shall not release the product for sale or distribution and shall immediately inform the relevant competent authorities.